What is Parkinson's Phase 3 Study CoQ10 QE3?

Category: Others

false

See also: Clinical Trial

NCT00740714 is a a clinical trial of the effects of Coenzyme Q10 with vitamin E in Parkinson Disease. Other study IDs includes: U01NS050324, QE3.

Reported purpose & perceived effectiveness
Purpose Patients Patients with evaluations Perceived Effectiveness
Evaluation/monitoring 1 1

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

side_effects of Parkinson's Phase 3 Study CoQ10 QE3"

Severe
0
Moderate
0
Mild
0
None
1

Dosages

Why Patients Stopped Using Parkinson's Phase 3 Study CoQ10 QE3 (multiple reasons could be selected)
Reason Patients
Other 1
See all 1 patient who’ve stopped using Parkinson's Phase 3 Study CoQ10 QE3

Duration

Stopped Using Parkinson's Phase 3 Study CoQ10 QE3
Duration Patients
0-1 month 0
1-3 months 0
3-6 months 0
6 months-1 year 0
1-2 years 1
2 years or more 0
Adherence
Always
0 0%
Usually
1 100%
Sometimes
0 0%
Never
0 0%
Burden
Very
0 0%
Somewhat
0 0%
A little
0 0%
Not at all
1 100%
Cost per month
$200+
0 0%
$100-199
0 0%
$50-99
0 0%
$25-49
0 0%
< $25
1 100%
Last updated:
There are no evaluations for Parkinson's Phase 3 Study CoQ10 QE3.